NMN is one of the main cellular energy sources in the human body. Since it is a precursor to NAD+, depletion in one compound will strongly affect the other. In recent preclinical studies, Nicotinamide Mononucleotide has been confirmed to have therapeutic properties. A remarkable breakthrough is realizing the compound’s huge role in reversing aging and slowing down the aging process. Recently, there is promising research on the cancer management of nicotinamide mononucleotide.
